(1)
Sarma, A.; Kataki, A. C.; Rai, A. K.; Hazarika, M.; Roy, P. S.; Kalita, M.; Deka, M.; Chattopadhyay, I. Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association With Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India. Asian Pac J Cancer Care 2023, 8, 35-42.